Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Schnitt · SciRah

Researcher profile · Semantic Scholar

S. Schnitt

Share profile

S. Schnitt — researcher profile on SciRah

h-index: 116
Works: 595
Citations: 49K

Most-cited papers

ESMO Expert Consensus Statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer.
P. Tarantino, G. Viale, M. Press, Xi-Chun Hu +28 more
2023Annals of Oncology307 citations Open access
Semantic Scholar
Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer.
P. Tarantino, Q. Jin, N. Tayob, R. Jeselsohn +12 more
2022JAMA Oncology207 citations Open access
Semantic Scholar
Validation and real-world clinical application of an artificial intelligence algorithm for breast cancer detection in biopsies
J. Sandbank, G. Bataillon, Alon Nudelman, Ira Krasnitsky +11 more
2022npj Breast Cancer100 citations Open access
Semantic Scholar
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.
E. S. Hwang, T. Hyslop, T. Lynch, Marc D. Ryser +33 more
2024Journal of the American Medical Association (JAMA)83 citations Open access
Semantic Scholar
Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer
M. De Schepper, A. Vincent-Salomon, M. Christgen, K. Van Baelen +29 more
2022Modern Pathology39 citations Open access
Semantic Scholar
Fully Automated Artificial Intelligence Solution for Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Scoring in Breast Cancer: A Multireader Study
Savitri Krishnamurthy, S. Schnitt, A. Vincent-Salomon, R. Canas-Marques +12 more
2024JCO Precision Oncology30 citations
Semantic Scholar
International Expert Consensus Recommendations for HER2 Reporting in Breast Cancer: Focus on HER2-low and Ultralow Categories.
E. Rakha, P. H. Tan, M. V. Van Bockstal, Kimberly H. Allison +30 more
2025Modern Pathology28 citations Open access
Semantic Scholar
Integration of pathological criteria and immunohistochemical evaluation for invasive lobular carcinoma diagnosis: recommendations from the European Lobular Breast Cancer Consortium.
M. De Schepper, T. Koorman, F. Richard, M. Christgen +16 more
2024Modern Pathology28 citations Open access
Semantic Scholar
Defining the Biology of Estrogen Receptor-Low-Positive Breast Cancer
Tessa Higgins, O. Kantor, Beth Harrison, Julia Giordano +10 more
2023Annals of Surgical Oncology22 citations
Semantic Scholar
Breast carcinomas of low malignant potential
S. Schnitt, F. Fend, T. Decker
2021Virchows Archiv22 citations
Semantic Scholar
NR4A3 Expression is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift
Edward T. Richardson, P. Selenica, F. Pareja, P. Dal Cin +6 more
2023Modern Pathology21 citations Open access
Semantic Scholar
Atypical Lobular Hyperplasia and Classic Lobular Carcinoma In Situ Can Be Safely Managed Without Surgical Excision
A. Laws, Fisher D. Katlin, F. Nakhlis, S. Chikarmane +2 more
2021Annals of Surgical Oncology21 citations
Semantic Scholar
Classification of fibroepithelial lesions of the breast in core needle biopsy with implications for further management.
E. Rakha, Cecily Quinn, Wendy A. Raymond, Kimberly H. Allison +37 more
2025Modern Pathology19 citations Open access
Semantic Scholar
Malignant phyllodes tumours of the breast: the case for revising WHO’s ‘full house’ diagnostic criteria
P. H. Tan, Ian O. Ellis, Kimberly H. Allison, S. Badve +38 more
2025Histopathology17 citations Open access
Semantic Scholar
Invasive lobular carcinoma with extracellular mucin (ILCEM): clinicopathologic and molecular characterization of a rare entity
T. R. Soong, D. Dillon, Travis Rice-Stitt, T. Wieczorek +6 more
2022Modern Pathology15 citations Open access
Semantic Scholar
Comparison of Breast Cancer Staging Systems After Neoadjuvant Chemotherapy
O. Kantor, A. Laws, R. Pastorello, C. King +5 more
2021Annals of Surgical Oncology13 citations
Semantic Scholar
Histopathologic Correlates of Nonmass Enhancement Detected by Breast Magnetic Resonance Imaging.
Vanda F. Torous, N. Resteghini, Jordana Phillips, V. Dialani +3 more
2021Archives of Pathology & Laboratory Medicine13 citations Open access
Semantic Scholar
Integrative Multiomic Profiling of Triple-Negative Breast Cancer for Identifying Suitable Therapies
B. Jovanović, Sarah E. Church, K. Gorman, Khrystyna North +12 more
2024Clinical Cancer Research11 citations Open access
Semantic Scholar
Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer
J. Guerriero, Jia-Ren Lin, R. Pastorello, Ziming Du +18 more
2024npj Breast Cancer11 citations Open access
Semantic Scholar
Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast Cancer
A. Laws, R. Pastorello, Tanujit Dey, S. Grossmith +5 more
2022Annals of Surgical Oncology11 citations
Semantic Scholar
World Health Organization classification of tumours of the breast 6th edition 2026
C. Quinn, P. H. Tan, Kimberly H. Allison, E. Brogi +24 more
2026Histopathology10 citations Open access
Semantic Scholar
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes
F. Pareja, R. Bhargava, V. Borges, E. Brogi +24 more
2025npj Breast Cancer10 citations Open access
Semantic Scholar
The Pathologists' Conundrum.
D. Rimm, S. Dacic, S. Schnitt
2022Archives of Pathology & Laboratory Medicine10 citations Open access
Semantic Scholar
A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR)
V. Bossuyt, E. Provenzano, W. Symmans, F. Webster +14 more
2024Histopathology9 citations
Semantic Scholar
Toker Cell Hyperplasia in the Nipple-areolar Complex of Transmasculine Individuals
G. Baker, Vanessa C Bret-Mounet, Jing-Xiong Xu, Valerie J. Fein-Zachary +8 more
2023Modern Pathology9 citations Open access
Semantic Scholar
A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast Cancer
Shom Goel, B. Jovanović, X. Chu, M. Hughes +10 more
2025Clinical Cancer Research8 citations Open access
Semantic Scholar
The American Society of Clinical Oncology-College of American Pathologists Guideline Update for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: How Low Can HER2 Go?
S. Schnitt, P. Tarantino, L. Collins
2023Archives of Pathology & Laboratory Medicine8 citations Open access
Semantic Scholar
Serous‐like breast carcinomas: immunophenotypic, genetic, and clinicopathologic characterization of a morphologically distinct group of tumours
Gregor Krings, E. Shamir, M. Laé, Gregory R. Bean +3 more
2024Histopathology7 citations
Semantic Scholar
Dataset for reporting of the invasive carcinoma of the breast: recommendations from the International Collaboration on Cancer Reporting (ICCR)
Ian O. Ellis, F. Webster, Kimberly H. Allison, Chau T. Dang +11 more
2024Histopathology7 citations Open access
Semantic Scholar
Effect of testosterone therapy on breast tissue composition and mammographic breast density in trans masculine individuals
Y. Heng, Gabrielle M. Baker, Valerie J Fein-Zachary, Yaileen D. Guzmán-Arocho +14 more
2024Breast Cancer Research7 citations Open access
Semantic Scholar
Ductal carcinoma in situ with and without microinvasion: is there a clinically meaningful difference in outcome?
R. Canas-Marques, S. Schnitt
2023British Journal of Cancer7 citations Open access
Semantic Scholar
Mucin Neovascularization as a Diagnostic Aid to Distinguish Mucinous Carcinomas From Mucocele-like Lesions in Breast Core Needle Biopsies
Allison M. Onken, L. Collins, S. Schnitt
2021American Journal of Surgical Pathology7 citations
Semantic Scholar
Pitfalls in the histological diagnosis of morphologic variants of invasive lobular carcinoma of the breast
G. Floris, L. Djerroudi, G. Zels, M. De Schepper +10 more
2025Modern Pathology6 citations Open access
Semantic Scholar
Salivary Gland-like Tumors of the Breast.
Edward T. Richardson, V. Jo, S. Schnitt
2023Archives of Pathology & Laboratory Medicine5 citations Open access
Semantic Scholar
Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or Ductal Carcinoma In Situ in Patients Diagnosed with Flat Epithelial Atypia by Core Needle Biopsy (TBCRC 034)
F. Nakhlis, Gabrielle M. Baker, Tian-Yu Li, Priscilla F. McAuliffe +14 more
2025Annals of Surgical Oncology4 citations
Semantic Scholar
An estrogen receptor signaling transcriptional program linked to immune evasion in human hormone receptor-positive breast cancer
Kenichi Shimada, Daniel E. Michaud, Y. Cui, Kelly F. Zheng +21 more
2024bioRxiv4 citations Open access
Semantic Scholar
Abstract CT142: TALAVE: Induction talazoparib (tala) followed by combined tala and avelumab in patients (pts) with advanced breast cancer (ABC)
F. Lynce, Kenichi Shimada, X. Geng, Edward T. Richardson +14 more
2023Cancer Research4 citations
Semantic Scholar
U.S. payer budget impact of using an AI-augmented cancer risk discrimination digital histopathology platform to identify high-risk of recurrence in women with early-stage invasive breast cancer
Salwa F. Masud, N. Mark, Thomas Goss, D. Malinowski +3 more
2024Journal of Medical Economics3 citations Open access
Semantic Scholar
Abstract P2-14-18: A randomized phase II trial of carboplatin with or without nivolumab in metastatic triple-negative breast cancer
A. Garrido-Castro, N. Graham, Kevin Bi, Jihye Park +29 more
2022Cancer Research3 citations
Semantic Scholar
Androgen receptor expression and immune characteristics of HER2-low metastatic triple-negative breast cancer
P. Tarantino, Jaeyoon Cha, Busem Binboğa Kurt, X. Chu +16 more
2026npj Breast Cancer2 citations
Semantic Scholar
Prognostic value of visually and computationally assessed tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer (TBCRC-030)
G. Nader-Marta, X. Chu, Satabhisa Mukhopadhyay, V. Abramson +17 more
2025Journal of the National Cancer Institute2 citations Open access
Semantic Scholar
Automated prediction of response to neoadjuvant chemotherapy from digitized H&E slides of pre-treatment core needle biopsies in germline BRCA carriers with HER2-negative breast cancer (TBCRC 031).
N. Tung, S. Schnitt, Judy E. Garber, Satabhisa Mukhopadhyay +2 more
2024Journal of Clinical Oncology2 citations
Semantic Scholar
Breast Myoepithelial Markers: Problems and Pitfalls for the Practicing Pathologist.
S. E. Bachert, Ellen Chapel, S. Schnitt
2025Human Pathology1 citations
Semantic Scholar
156 Differentiation Between HER2 Ultra-low and HER2 Null Breast Cancers Using an AI Support Tool: A Multi-Site Study
M. Grinwald, S. Schnitt, A. Vincent-Salomon, Savitri Krishnamurthy +13 more
2025Laboratory Investigation1 citations Open access
Semantic Scholar
APOE+ Tumor-Associated Macrophages and CD4-DOCK4 T Cells Reveal Distinct Microenvironmental Features in HER2-Low and HER2-0 Hormone Receptor-Positive Breast Cancer
C. Wanderley, Daniel E. Michaud, Kenichi Shimada, Adam Nelson +8 more
2025bioRxiv1 citations Open access
Semantic Scholar
Abstract PS12-06: A phase 2 study of abemaciclib monotherapy for patients with retinoblastoma-positive (Rb+), triple-negative metastatic breast cancer
S. Goel, B. Jovanović, X. Chu, M. Hughes +10 more
2024Cancer Research1 citations
Semantic Scholar
Identification of Glandular (Acinar)/Tubule Formation in Invasive Carcinoma of the Breast: A Study to Determine Concordance Using the World Health Organization Definition.
Yungtai Lo, Susan C. Lester, Ian O. Ellis, S. Lanjewar +36 more
2024Archives of Pathology & Laboratory Medicine1 citations Open access
Semantic Scholar
885 Characterization of the tumor microenvironment in advanced breast cancer patients treated with talazoparib followed by combination of talazoparib and avelumab
Kenichi Shimada, F. Lynce, Xue Geng, E.T. Richardson +15 more
2023Regular and Young Investigator Award Abstracts1 citations Open access
Semantic Scholar
Abstract P1-02-09: Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer (ILC)
M. De Schepper, A. Vincent-Salomon, M. Christgen, K. Van Baelen +26 more
2022Cancer Research1 citations
Semantic Scholar
Presence of Non-classic LCIS Is Not a Contraindication to Breast Conservation in Patients with Concomitant Invasive Breast Cancer or DCIS
F. Nakhlis, Fisher D. Katlin, S. Grossmith, Ashley M. DiPasquale +3 more
2022Annals of Surgical Oncology1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Vincent-Salomon×10
Invite
A. Vincent-Salomon — researcher profile on SciRah
S. Tolaney×8
Invite
S. Tolaney — researcher profile on SciRah
N. Tayob×7
Invite
N. Tayob — researcher profile on SciRah
P. H. Tan×6
Invite
P. H. Tan — researcher profile on SciRah

Kimberly H. Allison

×6

Invite

Kimberly H. Allison — researcher profile on SciRah

J. Guerriero×6

Invite

J. Guerriero — researcher profile on SciRah

P. Tarantino×5

Invite

P. Tarantino — researcher profile on SciRah

R. Jeselsohn×5

Invite

R. Jeselsohn — researcher profile on SciRah

Invite

T. King — researcher profile on SciRah

Invite

E. Rakha — researcher profile on SciRah

Invite

C. Desmedt — researcher profile on SciRah

Shabnam Jaffer×5

Invite

Shabnam Jaffer — researcher profile on SciRah